What the company does
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and …
What the weekly tape is saying
PFE closed the latest completed week at 22.61 EUR. The 4-week return is 3.6% and the 12-week return is -1.6%. Trend Signal is active, Market Dynamics is -0.65. Setup signature: Balanced read with a 56/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 22.07 EUR
- Vs Trend Line
- 2.4%
- Fair Value
- 22.13 EUR
- Vs Fair Value
- 2.2%
- 52W High
- 24.26 EUR
- 52W Low
- 18.91 EUR
- Drawdown
- -6.8%
- Range Position
- 69.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 37 weeks
- 52W Active Weeks
- 37
- 52W Active Breadth
- 71.2%
- Sector Scope
- AT Healthcare
- Sector Rank
- 50 of 112
- Sector Percentile
- 55.9%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
AT Healthcare
- Tracked Peers
- 100
- 4W Rank
- 53 of 100
- Avg 1W
- -1.0%
- Avg 4W
- 3.6%
- Trend Breadth
- 35.0%
- Positive MD
- 42.0%
AT Drug Manufacturers - General
- Tracked Peers
- 17
- 4W Rank
- 7 of 17
- Avg 1W
- -0.8%
- Avg 4W
- 2.5%
- Trend Breadth
- 58.8%
- Positive RS
- 17.6%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.65
- 4W MD Change
- 19.4%
- Relative Strength
- -12.28
- 4W RS Change
- -14.5%
- Expectation
- Positive
- Probability
- 55.06%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 6.2K
- 13W Average
- 3.7K
- 52W Average
- 4.5K
- Vs 13W
- 1.7x
- Vs 52W
- 1.4x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 2.5%
- 52W Volatility
- 3.4%
- Upside Weeks
- 29
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 2.5% / -2.4%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- VIE
- Country
- AT
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Currency
- EUR
- Market Cap
- 127.3B
Opportunity signals
- Trend Signal is active with a 37-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Market Dynamics is negative, which weakens the current setup.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 22.61 EUR | -0.2% | 22.07 EUR | 22.13 EUR | -0.65 | -12.28 | 6.2K | On |
| 5 Jun 2026 | 22.64 EUR | 1.9% | 22.01 EUR | 22.17 EUR | -0.91 | -10.01 | 4.3K | On |
| 29 May 2026 | 22.21 EUR | -0.3% | 21.93 EUR | 22.22 EUR | -1.02 | -12.87 | 2.4K | On |
| 22 May 2026 | 22.27 EUR | 2.1% | 21.84 EUR | 22.26 EUR | -0.96 | -10.51 | 1.6K | On |
| 15 May 2026 | 21.82 EUR | -0.5% | 21.76 EUR | 22.30 EUR | -0.80 | -10.72 | 2.0K | On |
| 8 May 2026 | 21.93 EUR | -1.9% | 21.69 EUR | 22.34 EUR | -0.41 | -10.81 | 2.1K | On |
| 1 May 2026 | 22.36 EUR | -0.1% | 21.63 EUR | 22.38 EUR | 0.05 | -7.94 | 4.1K | On |
| 24 Apr 2026 | 22.38 EUR | -1.6% | 21.62 EUR | 22.41 EUR | 0.56 | -7.50 | 2.1K | On |
| 17 Apr 2026 | 22.74 EUR | 0.7% | 21.51 EUR | 22.45 EUR | 1.03 | -9.48 | 3.9K | On |
| 10 Apr 2026 | 22.59 EUR | -6.9% | 21.39 EUR | 22.49 EUR | 1.26 | -8.17 | 5.4K | On |
| 3 Apr 2026 | 24.26 EUR | 4.3% | 21.29 EUR | 22.54 EUR | 1.41 | 4.73 | 3.4K | On |
| 27 Mar 2026 | 23.26 EUR | 1.3% | 21.14 EUR | 22.58 EUR | 1.41 | 3.65 | 4.8K | On |
| 20 Mar 2026 | 22.97 EUR | 0.4% | 21.03 EUR | 22.62 EUR | 1.36 | 3.58 | 6.0K | On |
| 13 Mar 2026 | 22.88 EUR | 2.5% | 20.96 EUR | 22.67 EUR | 1.31 | 1.51 | 7.9K | On |